Pompano Beach, Fla. -- Net income for PetMed Express dropped 31.7 percent from a year earlier.
Pompano Beach, Fla.
-- PetMed Express saw a decrease in net income for the fourth quarter, the company reported today.
In fact, net income for the company fell to $4.1 million vs. $6.1 million a year earlier, which is a 31.7 percent decline. Revenue rose 1.2 percent to 50.9 percent year-over year, according to the report. The company missed Wall Street analyst expectations, according to reports, and shares of the company (PETS) tumbled about 10.73 percent today.
In comments from Menderes Akdag, president and CEO, the company's financial performance was attributed to increased costs, decreased new order sales and increased competition.
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More